Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life

Vaccine

Volumn 30, Issue 39, 2012, Pages 5708-5713

  Wang, Yangyang ^a   Xu, Peizhen ^b   Zhu, Dongmei ^a   Zhang, Shu ^a   Bi, Yongchun ^a   Hu, Yali ^a   Zhou, Yi Hua ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b Changzhou Women's and Children's Hospital   (China)

Author keywords

Cytokine genes; Hepatitis B vaccine; Long term immune response; Polymorphism

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; RECOMBINANT HEPATITIS B VACCINE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HAPLOTYPES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNITY, HUMORAL; IMMUNOLOGIC MEMORY; INTERLEUKIN-4; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 2;

EID: 84864923648     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.07.010     Document Type: Article

References (35)

1. Ni Y.H., Chen D.S. Hepatitis B vaccination in children: the Taiwan experience. Pathol Biol (Paris) 2010, 58(4):296-300.
2. Poorolajal J., Mahmoodi M., Majdzadeh R., Nasseri-Moghaddam S., Haghdoost A., Fotouhi A. Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine 2010, 28(3):623-631.
3. Zhou Y.H., Wu C., Zhuang H. Vaccination against hepatitis B: the Chinese experience. Chin Med J (Engl) 2009, 122(1):98-102.
4. Lu F.M., Zhuang H. Prevention of hepatitis B in China: achievements and challenges. Chin Med J (Engl) 2009, 122(24):2925-2927.
5. Zuckerman J.N. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol 2006, 78(2):169-177.
6. Ertem D., Gonen I., Tanidir C., Ugras M., Yildiz A., Pehlivanoĝlu E., et al. The response to hepatitis B vaccine: does it differ in celiac disease?. Eur J Gastroenterol Hepatol 2010, 22(7):787-793.
7. Van Loveren H., Van Amsterdam J.G., Vandebriel R.J., Kimman T.G., Rumke H.C., Steerenberg P.S., et al. Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Environ Health Perspect 2001, 109(8):757-764.
8. Kacprzak-Bergman I., Nowakowska B. Influence of genetic factors on the susceptibility to HBV infection, its clinical pictures, and responsiveness to HBV vaccination. Arch Immunol Ther Exp (Warsz) 2005, 53(2):139-142.
9. Newport M.J., Goetghebuer T., Marchant A. Hunting for immune response regulatory genes: vaccination studies in infant twins. Expert Rev Vaccines 2005, 4(5):739-746.
10. Mineta M., Tanimura M., Tana T., Yssel H., Kashiwagi S., Sasazuki T. Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans. Int Immunol 1996, 8(4):525-531.
11. McDermott A.B., Zuckerman J.N., Sabin C.A., Marsh S.G., Madrigal J.A. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997, 50(1):8-14.
12. Caillat-Zucman S., Gimenez J.J., Wambergue F., Albouze G., Lebkiri B., Naret C., et al. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int 1998, 53(6):1626-1630.
13. Langö-Warensjö A., Cardell K., Lindblom B. Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response after immunisation with hepatitis B surface antigen. Tissue Antigens 1998, 52(4):374-380.
14. Wang C., Tang J., Song W., Lobashevsky E., Wilson C.M., Kaslow R.A. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004, 39(4):978-988.
15. Höhler T., Reuss E., Evers N., Dietrich E., Rittner C., Freitag C.M., et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 2002, 360(9338):991-995.
16. Li Y., Ni R., Song W., Shao W., Shrestha S., Ahmad S., et al. Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum Genet 2009, 126(5):685-696.
17. Godkin A., Davenport M., Hill A.V. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 2005, 41(6):1383-1390.
18. Yucesoy B., Sleijffers A., Kashon M., Garssen J., de Gruijl F.R., Boland G.J., et al. IL-1beta gene polymorphisms influence hepatitis B vaccination. Vaccine 2002, 20(25-26):3193-3196.
19. Macedo L.C., Isolani A.P., Visentainer J.E., Moliterno R.A. Association of cytokine genetic polymorphisms with the humoral immune response to recombinant vaccine against HBV in infants. J Med Virol 2010, 82(6):929-933.
20. Yucesoy B., Johnson V.J., Fluharty K., Kashon M.L., Slaven J.E., Wilson N.W., et al. Influence of cytokine gene variations on immunization to childhood vaccines. Vaccine 2009, 27(50):6991-6997.
21. Höhler T., Reuss E., Freitag C.M., Schneider P.M. A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A. Hepatology 2005, 42(1):72-76.
22. Chen J., Liang Z., Lu F., Fang X., Liu S., Zeng Y., et al. Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine. Vaccine 2011, 29(4):706-711.
23. Hennig B.J., Fielding K., Broxholme J., Diatta M., Mendy M., Moore C., et al. Host genetic factors and vaccine-induced immunity to hepatitis B virus infection. PLoS ONE 2008, 3(3):e1898.
24. Lin Y.J., Lan Y.C., Wan L., Lin T.H., Chen D.Y., Tsai C.H., et al. Serological surveillance and IL-10 genetic variants on anti-HBs titers: hepatitis B vaccination 20 years after neonatal immunization in Taiwan. Clin Chim Acta 2011, 412(9-10):766-773.
25. Ji F., Finch S.J., Haynes C., Mendell N.R., Gordon D. Incorporation of genetic model parameters for cost-effective designs of genetic association studies using DNA pooling. BMC Genomics 2007, 8:238.
26. Smith N.L., Hindorff L.A., Heckbert S.R., Lemaitre R.N., Marciante K.D., Rice K., et al. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA 2007, 297(5):489-498.
27. Thomas C., Moridani M. Interindividual variations in the efficacy and toxicity of vaccines. Toxicology 2010, 278(2):204-210.
28. Van der Wielen M., Van Damme P., Chlibek R., Smetana J., von Sonnenburg F. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors. Vaccine 2006, 24(26):5509-5515.
29. Dhiman N., Ovsyannikova I.G., Cunningham J.M., Vierkant R.A., Kennedy R.B., Pankratz V.S., et al. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis 2007, 195(1):21-29.
30. Wiertsema S.P., Baynam G., Khoo S.K., Veenhoven R.H., van Heerbeek N., Zhang G., et al. Impact of genetic variants in IL-4, IL-4 RA and IL-13 on the anti-pneumococcal antibody response. Vaccine 2007, 25(2):306-313.
31. Punnonen J., Yssel H., de Vries J.E. The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells. J Allergy Clin Immunol 1997, 100(6 Pt 1):792-801.
32. Jafarzadeh A., Shokri F. The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates. Clin Exp Immunol 2003, 131(3):451-456.
33. Amirzargar A.A., Movahedi M., Rezaei N., Moradi B., Dorkhosh S., Mahloji M., et al. Polymorphisms in IL4 and IL4RA confer susceptibility to asthma. J Investig Allergol Clin Immunol 2009, 19(6):433-438.
34. Bozzi A., Reis B.S., Pereira P.P., Pedroso E.P., Goes A.M. Interferon-gamma and interleukin-4 single nucleotide gene polymorphisms in Paracoccidioidomycosis. Cytokine 2009, 48(3):212-217.
35. Sleijffers A., Yucesoy B., Kashon M., Garssen J., De Gruijl F.R., Boland G.J., et al. Cytokine polymorphisms play a role in susceptibility to ultraviolet B-induced modulation of immune responses after hepatitis B vaccination. J Immunol 2003, 170(6):3423-3428.